|
Product Information |
|
Product name |
Ferric Carboxymaltose |
|
CAS No. |
9007-72-1 |
|
Molecular Formula |
C39H63FeO39 |
|
Molecular Weight |
1211.74 |
|
Quality Standard |
Assay of Iron ≥ 31% |
|
Appearance |
Yellow brown to brown powder |
|
COA |
|
Test Items |
Specifications |
Results |
|
Appearance |
Yellow brown to brown powder |
Brown powder |
|
Identification for Iron |
It responds to the test for iron |
Positive reaction |
|
Identification by TLC |
The position and color of the spots shown by the sample solution are the same as the spot of standard solution (a) |
The position and color of the spots shown by the sample solution should be the same as the spot of standard solution (a). |
|
pH |
5.0 - 7.0 |
5.6 |
|
Molecular weight determination (Da, by gel permeation chromatography (GPC)) |
Weight-average molecular weight (Mw) between 130,000 to 200,000 |
180,896 |
|
Number-average molecular weight (Mn) not less than 70,000 |
109,035 |
|
|
Polydispersity (Mw/Mn) not more than 1.9 |
1.66 |
|
|
Sodium Chloride content (w/w, on as is basis by Potentiometry) |
≤ 6.0% |
4.1 |
|
Limit of Fe(Ⅱ) (w/w, on as-is basis by potentiometry titration) |
≤1.2% |
0.07% |
|
Residual solvents (by GC-HS) |
Ethanol ≤ 0.5% |
0.40% |
|
Elemental impurities (μg/g by ICP-MS) |
Cd ≤ 0.2 μg/g |
0.004 μg/g |
|
As ≤ 0.2 μg/g |
0.016 μg/g |
|
|
Co ≤ 0.5 μg/g |
0.343 μg/g |
|
|
V ≤ 1.0 μg/g |
0.028 μg/g |
|
|
Ni ≤ 2.0 μg/g |
0.127 μg/g |
|
|
Cr ≤ 50 μg/g |
0.219 μg/g |
|
|
Mo ≤ 50 μg/g |
0.050 μg/g |
|
|
Cu ≤ 30 μg/g |
0.040 μg/g |
|
|
Li ≤ 25 μg/g |
Not detected |
|
|
Kb ≤ 0.5 μg/g |
0.007 μg/g |
|
|
Hg ≤ 0.3 μg/g |
Not detected |
|
|
Sb ≤ 9.0 μg/g |
0.005 μg/g |
|
|
Loss on drying (w/w) |
<8.5% |
6.8% |
|
Bacterial endotoxin |
< 0.1 EU/mg Fe |
Conforms |
|
Microbial limit |
Total Aerobic Microbial count ≤ 100 cfu/g |
Conforms |
|
Total Yeasts and Molds count ≤ 100 cfu/g |
Conforms |
|
|
Escherichia coli: absent/g |
Absent |
|
|
Staphylococcus aureus: absent/g |
Absent |
|
|
Pseudomonas aeruginosa: absent/g |
Absent |
|
|
Salmonella: absent/10g |
Absent |
|
|
Assay of Iron |
24.0% ~ 32.0% |
31.1% |
|
Assay of Dextrin |
30.0% ~ 45.0% |
37.0% |
|
Usage |
Ferric carboxymaltose (FCM), a next-generation intravenous iron therapy, features a unique core-shell structure (β-FeOOH core + carboxymaltose shell) that ensures controlled iron release, minimizing oxidative toxicity risks. With high iron content (47.5–52.5 mg/mL), it enables rapid infusion (15 mins for 500–1,500 mg iron), reducing dosing frequency and improving patient compliance.
Advantages of Sinoway’s Ferric carboxymaltose:
1. Cost-Effective Scaling: Chinese API manufacturers leverage mature fermentation and chemical synthesis technologies to produce FCM at competitive prices.
2. GMP Compliance: Facilities adhere to USP/EP standards and pass FDA/EMA audits, ensuring global quality compliance.
3. Supply Chain Efficiency: Integrated raw material (e.g., maltodextrin) sourcing shortens lead times for bulk orders.
Ideal for iron deficiency anemia treatment, FCM exemplifies China’s capability in high-value pharmaceutical manufacturing.